Pacific Edge Limited (PEB) Share Forecast & Price Target
PEB Analyst Ratings
There are no analyst ratings in the last 3 months.
PEB Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Adrian Allbon | Jarden | AUD 0.20 | hold | 5.26%Upside | Reiterated | 07/14/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Adrian Allbon | 07/14/26 | AUD 0.20 | hold | 5.26%Upside | Reiterated | Jarden |
Best Analysts Covering Pacific Edge Limited
Copying Anthropic Medical - Diagnostics and Research's trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of 0.00% per trade.
Copying Anthropic Medical - Diagnostics and Research's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of 0.00% per trade.
Copying Anthropic Medical - Diagnostics and Research's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of 0.00% per trade.
PEB Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 3 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 2 | 3 | 1 | 1 | 0 |
In the current month, PEB has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. PEB average Analyst price target in the past 3 months is ―.
PEB Financial Forecast
PEB Earnings Forecast
Next quarter’s earnings estimate for PEB is -AUD 0.01 with a range of ― to ―. The previous quarter’s EPS was -AUD 0.01. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
PEB Sales Forecast
Next quarter’s sales forecast for PEB is AUD 4.44M with a range of ― to ―. The previous quarter’s sales results were AUD 4.44M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
